Synergism between adriamycin and coxsackie virus group B type 3 (CVB3) in induction of myocardial injury: potential role for gamma/delta TcR+ T lymphocytes in pathogenesis.
Moraska
A
A
Department of Pathology, College of Medicine, University of Vermont, Burlington 05405.
Huber
S A
SA
D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D001327:Autoimmune Diseases / Q000209:etiology*; D003384:Coxsackievirus Infections / Q000150:complications*; D003429:Cross Reactions; D003602:Cytotoxicity, Immunologic; D004317:Doxorubicin / Q000009:adverse effects*; D029822:Enterovirus B, Human / Q000276:immunology; D006360:Heat-Shock Proteins / Q000276:immunology; D006358:Hot Temperature; D051379:Mice; D008807:Mice, Inbred BALB C; D009205:Myocarditis / Q000209:etiology*; D013601:T-Lymphocytes / Q000276:immunology*
D000956:Antigens, Viral; D006360:Heat-Shock Proteins; D004317:Doxorubicin